Search results for "Mort"

showing 10 items of 1955 documents

The Management of Staphylococcal Toxic Shock Syndrome. A Case Report

2016

Abstract Staphylococcal toxic shock syndrome (TSS) is most frequently produced by TSS toxin-1 (TSST-1) and Staphylococcal enterotoxin B (SEB), and only rarely by enterotoxins A, C, D, E, and H. Various clinical pictures can occur depending on severity, patient age and immune status of the host. Severe forms, complicated by sepsis, are associated with a death rate of 50-60%. The case of a Caucasian female infant, aged seven weeks, hospitalized with a diffuse skin rash, characterized as allergodermia, who initially developed TSS with axillary intertrigo, is reported. TSS was confirmed according to 2011 CDC criteria, and blood cultures positive for Methicillin-sensitive Staphylococcus aureus (…

0301 basic medicinemedicine.medical_specialtyIntertrigogenetic structuresmedicine.drug_classAntibioticsCase Reportmedicine.disease_causetssSepsis03 medical and health sciences0302 clinical medicine030225 pediatricsInternal medicinemedicineAcidosisRC86-88.9business.industryMortality rateMedical emergencies. Critical care. Intensive care. First aidstaphylococcal toxic shock syndromebacterial infections and mycosesmedicine.diseaseRash030104 developmental biologyStaphylococcus aureusSuperinfectionmedicine.symptombusinessmanagementThe Journal of Critical Care Medicine
researchProduct

Association of statin use and clinical outcomes in heart failure patients : a systematic review and meta-analysis

2019

Abstract Background The role of statins in patients with heart failure (HF) of different levels of left ventricular ejection fraction (LVEF) remains unclear especially in the light of the absence of prospective data from randomized controlled trials (RCTs) in non-ischemic HF, and taking into account potential statins’ prosarcopenic effects. We assessed the association of statin use with clinical outcomes in patients with HF. Methods We searched PubMed, EMBASE, Scopus, Google Scholar and Cochrane Central until August 2018 for RCTs and prospective cohorts comparing clinical outcomes with statin vs non-statin use in patients with HF at different LVEF levels. We followed the guidelines of the 2…

0301 basic medicinemedicine.medical_specialtyStatinmedicine.drug_classEndocrinology Diabetes and MetabolismClinical Biochemistry610Heart failure030204 cardiovascular system & hematologyLower risklaw.invention03 medical and health sciences0302 clinical medicineEndocrinologyRandomized controlled trialHeart failure; Hospitalization; Meta-analysis; Mortality; StatinslawInternal medicineHumansMedicineCardiac and Cardiovascular SystemsProspective StudiesMortalitylcsh:RC620-627Kardiologibusiness.industryResearchBiochemistry (medical)Hazard ratioStatinsmedicine.diseaseConfidence interval3. Good healthHospitalizationlcsh:Nutritional diseases. Deficiency diseasesMeta-analysisTreatment Outcome030104 developmental biologyMeta-analysisHeart failureHydroxymethylglutaryl-CoA Reductase InhibitorsbusinessCohort study
researchProduct

Atherothrombosis and Thromboembolism: Position Paper from the Second Maastricht Consensus Conference on Thrombosis

2018

AbstractAtherothrombosis is a leading cause of cardiovascular mortality and long-term morbidity. Platelets and coagulation proteases, interacting with circulating cells and in different vascular beds, modify several complex pathologies including atherosclerosis. In the second Maastricht Consensus Conference on Thrombosis, this theme was addressed by diverse scientists from bench to bedside. All presentations were discussed with audience members and the results of these discussions were incorporated in the final document that presents a state-of-the-art reflection of expert opinions and consensus recommendations regarding the following five topics: 1. Risk factors, biomarkers and plaque inst…

0301 basic medicinemedicine.medical_specialtyanticoagulantsADJUST ANTIPLATELET THERAPYPERCUTANEOUS CORONARY INTERVENTION030204 cardiovascular system & hematologyarterial thrombosisArticleantiplatelet therapyACTIVATED PROTEIN-CRED-BLOOD-CELLS03 medical and health sciences0302 clinical medicineVITAMIN-K ANTAGONISTSInternal medicineatherothrombosisIschaemic strokeNONVALVULAR ATRIAL-FIBRILLATIONmedicinePlateletatrial fibrillationACUTE ISCHEMIC-STROKEcoagulationATOMIC-FORCE MICROSCOPYCardiovascular mortalityischaemic strokeAtomic force microscopybusiness.industryConsensus conferenceHematologymedicine.diseaseThrombosis030104 developmental biologymyocardial infarctionCoagulationplateletsDIRECT ORAL ANTICOAGULANTSCardiologyPosition paperSYMPTOMATIC VENOUS THROMBOEMBOLISMatherosclerosisbusiness
researchProduct

Subnational mapping of HIV incidence and mortality among individuals aged 15-49 years in sub-Saharan Africa, 2000-18: a modelling study

2021

Background. High-resolution estimates of HIV burden across space and time provide an important tool for tracking and monitoring the progress of prevention and control efforts and assist with improving the precision and efficiency of targeting efforts. We aimed to assess HIV incidence and HIV mortality for all second-level administrative units across sub-Saharan Africa. Methods. In this modelling study, we developed a framework that used the geographically specific HIV prevalence data collected in seroprevalence surveys and antenatal care clinics to train a model that estimates HIV incidence and mortality among individuals aged 15–49 years. We used a model-based geostatistical framework to e…

0301 basic medicinesub-Saharan AfricaMaleHIV AntibodieEpidemiologyHIV incidencesHIV Infectionsmortality rateHIV AntibodiesModelling studyHuman immunodeficiency virus prevalence0302 clinical medicineAfrica NorthernRA0421Seroepidemiologic StudiesMedicineNorthernHIV Infection030212 general & internal medicineYoung adult10. No inequalityuncertaintyMozambique11 Medical and Health SciencesHIV mortalityMortality rateIncidence (epidemiology)Incidence1. No povertyHiv incidencearticleMauritaniaHuman immunodeficiency virus infected patientArticlestrackingMiddle Agedhealth care planning3. Good healthPeer reviewLesothoAIDSInfectious DiseasesQR180A990 Medicine and Dentistry not elsewhere classifiedFemaleprenatal careanti human immunodeficiency virus agentseroepidemiologyHumanAdultAdolescentAnti-HIV AgentsImmunologyantiretroviral therapyUnit (housing)03 medical and health sciencesYoung AdultbloodHuman immunodeficiency virus infectionVirologySeroprevalenceHumanshumanDeveloping CountriesEstimationAcquired Immunodeficiency SyndromeSubnational mappingsbusiness.industrySeroepidemiologic StudieHIVAnti-HIV AgentPREVENTION030112 virologymortalitymonitoring3121 General medicine internal medicine and other clinical medicineHuman immunodeficiency virus antibodyAfricabusinessHIV incidence ; HIV mortality ; Subnational mapping ; Sub-Saharan Africa ; Local burden of disease ; Public healthDemography
researchProduct

Exploring the association between extra-cardiac troponin elevations and risk of future mortality

2019

Although the measurement of cardiac troponin I (cTnI) and T (cTnT) has now become the cornerstone for diagnosing cardiac injury, both ischemic and non-ischemic, recent evidence has become available that many patients display extra-cardiac causes of cTn elevations and carry a considerably enhanced risk of future mortality. The current literature data suggests that cTn elevations may be equally common in patients with cardiac and extra-cardiac diseases. Among the latter cohort of patients, the leading extra-cardiac diseases which may be responsible for either cTnI or cTnT elevations include infectious diseases/sepsis, pulmonary disorders, renal failure, malignancy, as well as gastrointestinal…

030213 general clinical medicinemedicine.medical_specialtycardiac injuryClinical Biochemistry030209 endocrinology & metabolismSepsislcsh:Biochemistry03 medical and health sciences0302 clinical medicineTroponin complexInternal medicineTroponin IOpinion Papermedicinelcsh:QD415-436Myocardial infarctionStrokeCause of deathbiologybusiness.industrytroponinBiochemistry (medical)medicine.diseaseTroponinmortalitymyocardial infarctionHeart failurecardiac injury mortality myocardial infarction troponinCardiologybiology.proteincardiovascular systembusinessJournal of Medical Biochemistry
researchProduct

2020

Through a recent upsurge of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic, the clinical assessment of most of the coronavirus disease 19 (COVID-19) patients clearly presents a health condition with the loss of oro-naso-sensory (ONS) perception, responsible for the detection of flavor and savor. These changes include anosmia and dysgeusia. In some cases, these clinical manifestations appear even before the general flu-like symptoms, e.g., sore throat, thoracic oppression and fever. There is no direct report available on the loss of these chemical senses in obese COVID-19 patients. Interestingly, obesity has been shown to be associated with low ONS cues. These alterati…

0303 health sciencesmedicine.medical_specialtybusiness.industryMortality ratemedicine.medical_treatmentAnosmia030209 endocrinology & metabolismImmunosuppressionGeneral MedicineDiseasemedicine.diseaseObesityDysgeusia03 medical and health sciences0302 clinical medicineInternal medicineSore throatMedicinemedicine.symptomRisk factorbusiness030304 developmental biologyJournal of Clinical Medicine
researchProduct

Reclaimed asphalt binders and mortars fatigue behaviour

2017

Fatigue cracking is one of the most important failure mechanisms occurring in asphalt pavements, especially when mixtures incorporate considerable amount of rReclaimed asphalt pavement (RAP). In fact, aged binders contained in RAP generally make asphalt more brittle and specifically reduce fatigue resistance of the resulting asphalt mixtures. Binders and mortars play a key role in this phenomenon, considering fatigue cracking usually starts within these asphalt components. However, performance-related tests and specifications commonly regard binders and there are no sound methodologies allowing the use of mortars to predicting fatigue performance of asphalts containing RAP. For this reason,…

050210 logistics & transportationMaterials scienceFatigue cracking05 social sciences0211 other engineering and technologies02 engineering and technologyFatigue limitReclaimed asphalt pavementFatigue resistanceBrittlenessAsphalt pavementtime sweepAsphalt021105 building & construction0502 economics and businessmortarSettore ICAR/04 - Strade Ferrovie Ed AeroportifatigueMortarComposite materialCement mortarfatigue; mortar; Reclaimed asphalt pavement; time sweep; Civil and Structural EngineeringCivil and Structural Engineering
researchProduct

Another "French paradox": explaining why interest rates to microenterprises dit not increase with the change in French usury legislation

2015

Conventional wisdom indicates that the growth of credit may not materialize if credit rates remain capped by usury laws, as had long been the case in France. France therefore abolished usury ceilings on loans to microenterprise in an effort to increase financing for microentrepreneurs. This should have led to an increase in interest rates and increase in microcredit. However, we do not find any increase in interest rates and this is therefore a paradox. The paper provides a brief literature review and the salient features of the legislative changes in France. It follows this up with a presentation of interest rate movements. The discussion of possible explanations of the paradox includes cl…

060106 history of social sciencesMonetary economicsBehavioral economicslaw.inventionUsuryInformation asymmetry[ QFIN ] Quantitative Finance [q-fin]JEL: G - Financial Economics/G.G2 - Financial Institutions and Services/G.G2.G21 - Banks • Depository Institutions • Micro Finance Institutions • Mortgages[SHS.DROIT]Humanities and Social Sciences/LawlawEconomicsInstitutional analysis0601 history and archaeologyJEL : B - History of Economic Thought Methodology and Heterodox Approaches/B.B5 - Current Heterodox Approaches/B.B5.B59 - Other050207 economicsmedia_commonusury050208 finance[QFIN]Quantitative Finance [q-fin]Limited liability05 social sciences1. No povertybehavioural finance06 humanities and the artsJEL: B - History of Economic Thought Methodology and Heterodox Approaches/B.B5 - Current Heterodox Approaches/B.B5.B52 - Institutional • EvolutionaryInterest rateJEL : K - Law and Economics/K.K0 - General/K.K0.K00 - General8. Economic growth[SHS.GESTION]Humanities and Social Sciences/Business administrationJEL: B - History of Economic Thought Methodology and Heterodox Approaches/B.B5 - Current Heterodox Approaches/B.B5.B59 - OtherJEL: E - Macroeconomics and Monetary Economics/E.E4 - Money and Interest RatesEconomics and Econometricsmedia_common.quotation_subjectMoney supplyLegislationBasel IIConventional wisdom[ SHS.DROIT ] Humanities and Social Sciences/LawJEL : E - Macroeconomics and Monetary Economics/E.E4 - Money and Interest Rates0502 economics and businessBusiness and International Management[ SHS.GESTION ] Humanities and Social Sciences/Business administrationFinanceMicrofinancebusiness.industryJEL : G - Financial Economics/G.G2 - Financial Institutions and Services/G.G2.G21 - Banks • Depository Institutions • Micro Finance Institutions • MortgagesJEL : B - History of Economic Thought Methodology and Heterodox Approaches/B.B5 - Current Heterodox Approaches/B.B5.B52 - Institutional • Evolutionarylaw and economicsinstitutional analysismicrofinancemicrocreditJEL: K - Law and Economics/K.K0 - General/K.K0.K00 - GeneralbusinessLawinterest rate
researchProduct

2016

Summary Background Improving survival and extending the longevity of life for all populations requires timely, robust evidence on local mortality levels and trends. The Global Burden of Disease 2015 Study (GBD 2015) provides a comprehensive assessment of all-cause and cause-specific mortality for 249 causes in 195 countries and territories from 1980 to 2015. These results informed an in-depth investigation of observed and expected mortality patterns based on sociodemographic measures. Methods We estimated all-cause mortality by age, sex, geography, and year using an improved analytical approach originally developed for GBD 2013 and GBD 2010. Improvements included refinements to the estimati…

2. Zero hungerGerontologyeducation.field_of_studybusiness.industryMortality ratePopulation1. No povertyGeneral Medicine030204 cardiovascular system & hematologyVerbal autopsy3. Good health03 medical and health sciencesEpidemiological transition0302 clinical medicineYears of potential life lostLife expectancyCompensation law of mortalityMedicine030212 general & internal medicinebusinesseducationDemographyCause of deathThe Lancet
researchProduct

2017

Importance: Comprehensive and timely monitoring of disease burden in all age groups, including children and adolescents, is essential for improving population health.Objective: To quantify and describe levels and trends of mortality and nonfatal health outcomes among children and adolescents from 1990 to 2015 to provide a framework for policy discussion.Evidence Review: Cause-specific mortality and nonfatal health outcomes were analyzed for 195 countries and territories by age group, sex, and year from 1990 to 2015 using standardized approaches for data processing and statistical modeling, with subsequent analysis of the findings to describe levels and trends across geography and time among…

2. Zero hungerGerontologyeducation.field_of_studybusiness.industryPopulation1. No poverty3. Good healthChild mortality03 medical and health sciencesEpidemiological transition0302 clinical medicine030225 pediatricsEnvironmental healthPediatrics Perinatology and Child HealthGlobal healthLife expectancyMedicine030212 general & internal medicinebusinesseducationDisease burdenReproductive healthAdolescent healthJAMA Pediatrics
researchProduct